Ajanta Pharma

AJANTAPHARMA28 Mar 2024
Pharmaceuticals
+37.35 (+1.70%)
Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
To Invest in Ajanta Pharma
Ajanta Pharma
Pharmaceuticals
AJANTAPHARMA28 Mar 2024
+37.35 (+1.70%)
OverviewFundamentals
1D
1M
6M
1Y
5Y
All

Ajanta Pharma - Share Price & Details

Lowest Today
2173.6
Highest Today
2247.95
Today’s Open
2179.35
Prev. Close
2193.5
52 Week High
2353.95
52 Week Low
1155.1
Traded Volume
Market Cap(Cr)
Avg Traded Price
1 Year return
92.25%
Upper Circuit
Lower Circuit
P/E TTM
36.99
P/B Ratio
8.40
Traded Value(Cr)
0.00
EPS TTM
60.5
Book value
Dividend
0.31%

Price Performance

4.94 %
1 Wk
6.99 %
1 M
11.86 %
3 M
92.25 %
1 Y
3.30 %
YTD

Traded Volume Movement

Technical Details

Support 3
2113
Support 2
2144
Support 1
2187
Pivot Point :
2218
Resistance 1
2262
Resistance 2
2292
Resistance 3
2336

Reports

Peer Comparison

Scrip NamePriceDaily ChangeM.Cap (Cr)1 Year Returns %P/E (TTM)PB Ratio
Ajanta Pharma Ltd
₹2,230.85(+37.35/1.70%)
2,230.85+37.3528,090.1292.2536.998.40
Lupin Ltd
₹1,616.80(+16.85/1.05%)
1,616.80+16.8573,665.75150.9035.773.82
J B Chemicals & Pharmaceuticals Ltd
₹1,650.40(+7.50/0.46%)
1,650.40+7.5025,613.3568.3950.579.54
Ipca Laboratories Ltd
₹1,237.40(+32.10/2.66%)
1,237.40+32.1031,393.3656.3357.065.06
Sanofi India Ltd
₹8,113.95(+153.15/1.92%)
8,113.95+153.1518,686.4344.1831.6618.41
361.45+0.652,121.9130.1812.301.34

About Ajanta Pharma Ltd

Ajanta Pharma Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 28181.41 crores. It has reported a sales of Rs. 1085.29 crores and a net profit of Rs. 220.15 crores for the quarter ended December 2018. The company management includes Mannalal B Agrawal, Mannalal B Agrawal,Madhusudan B Agrawal,Yogesh Agrawal,Chandrakanth M Khetan,Gaurang Shah,Rajesh M Agrawal,K H Viswanathan,Prabhakar Dalal,Anjana Grewal (Ajanta Pharma Ltd) among others.
Chairman
Mannalal B Agrawal
Registered office
Ajanta House,Charkop Kandivli (W),Mumbai,Maharashtra,400067
FAX :91-22-66061200/1300
Background
Incorporation Year1979
Face Value₹2
Market Lot1

Latest News

Stupendous FY24 drives market cap of 25 cos by Rs 1 lakh crore
A stellar run by domestic equities in FY24 saw the market capitalization of 25 companies rise by atleast Rs 1 lakh crore in a year. Of this, 17 of them are part of benchmark Nifty 50.The Nifty has gained nearly 29% in FY24 and it also tested a lifetime high after a muted show in FY23.Robust corporate earnings, high capital investments by the government, strong domestic economic growth.
29 Mar 2024 | 11:43 AM
Buy or sell: Rajesh Palviya of Axis Securities recommends to buy, hold?
Stock Market News: Domestic equity benchmark indices, the Sensex and Nifty 50, finished Thursday's session—the final trading day of the fiscal year 2024—with strong gains amidst favourable global cues. Nifty 50 zoomed around 30% in FY24, and Sensex surged about 28% in the same period. On Thursday, the 30-share BSE Sensex closed higher by 655.04 points or 0.90% at 73,651.35 level.
29 Mar 2024 | 11:02 AM
Short-term picks: Three stocks that may generate 17-25% returns
The Nifty 50 index has consistently displayed a bullish price structure, characterised by higher top, higher bottom formations, and is hovering near its all-time high levels on the monthly charts, indicating a strong positive sentiment for the long term. Recently, the index found significant support at the 13-week EMA (exponential moving average) and formed a notable Bullish Opening.
29 Mar 2024 | 10:01 AM
Three stocks to bet on for 17-25% return as bulls may rule Nifty
The Nifty 50 index has consistently displayed a bullish price structure, characterised by higher top, higher bottom formations, and is hovering near its all-time high levels on the monthly charts, indicating a strong positive sentiment for the long term. Recently, the index found significant support at the 13-week EMA (exponential moving average) and formed a notable Bullish Opening.
29 Mar 2024 | 11:07 AM
Buy or sell: Rajesh Palviya of Axis Securities recommends to buy, hold?
Stock Market News: Domestic equity benchmark indices, the Sensex and Nifty 50, finished Thursday's session—the final trading day of the fiscal year 2024—with strong gains amidst favourable global cues. Nifty 50 zoomed around 30% in FY24, and Sensex surged about 28% in the same period. On Thursday, the 30-share BSE Sensex closed higher by 655.04 points or 0.90% at 73,651.35 level.
29 Mar 2024 | 11:02 AM

How to buy Ajanta Pharma shares on nse?

To buy Ajanta Pharma shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Ajanta Pharma share price today?

The Ajanta Pharma shares price on nse is Rs.2230.85 today.

What is the market cap of Ajanta Pharma shares on NSE ?

The company has a market capitalization of Rs.28090.12Cr

What is the PE & PB ratio of Ajanta Pharma shares ?

PE is 36.99 and PB is 8.4

What is the 52 Week High and Low of Ajanta Pharma shares?

Ajanta Pharma stock price high: Rs.2353.95 Ajanta Pharma stock price low: Rs.1155.1

How can I purchase Ajanta Pharma stock with Motilal Oswal?

You can easily purchase Ajanta Pharma stock by signing up with ace broker Motilal Oswal and opening a demat account. Then you will have to open a trading account linked with your demat account and this helps you to conduct transactions (buy and sell stock). After this, you can buy Ajanta Pharma stock on the stock exchange through Motilal Oswal. 

Is Ajanta Pharma a good investment?

According to price and trend analysis, experts say that Ajanta Pharma is a semi-strong stock investment. This means that the stock may rise to a certain extent in the short run. Depending on investment needs and goals, you can invest accordingly. 

Is Ajanta Pharma debt free?

In September 2022, Ajanta Pharma held a debt of Rs. 284.8 million. This was higher by more than Rs. 200 million from the previous year.

What is the dividend yield of Ajanta Pharma?

The dividend yield of Ajanta Pharma is 0.82% (March 2022).

setTimeout(function() { }, 5000);